Today: 19 May 2026
Browse Category

NASDAQ:GNTA 24 October 2025

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science shares surged over 300% in early trading Oct. 24 after announcing an expanded partnership with Anemocyte to develop off-the-shelf lentiviral vector plasmid DNA for cell therapies. The company’s lead candidate Temferon showed a 29% two-year survival rate in glioblastoma patients, more than double standard care. Net loss narrowed to €3.83M in H1 2025. Analyst targets average $22.73, far above current prices.
24 October 2025
··

Stock Market Today

  • JBS Q1 2026 Earnings Review and Valuation Amid Brazil-USA Summit
    May 19, 2026, 1:38 AM EDT. JBS reported Q1 2026 sales of $21.6 billion and net income of $220.6 million, yet its share price dropped 27.4% over 30 days, reflecting weak short-term momentum. Trading at $12.86, JBS is viewed as 35.8% undervalued versus a fair value of $20.04, driven by expectations of global protein demand growth and multi-protein platform advantages. Risks include tight U.S. cattle supply and rising input costs impacting margins and cash flow. Investors should weigh long-term growth potential against these pressures, considering JBS's mixed earnings and current market pricing in their investment decisions.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

ServiceNow Jumps After Wall Street Shifts AI View

ServiceNow Jumps After Wall Street Shifts AI View

19 May 2026
ServiceNow shares surged 8.8% to $103.42 Monday after Bank of America reinstated coverage with a Buy rating and $130 target. Volume hit 50.74 million shares, nearly double the average. The move contrasted with a broader tech selloff as the Nasdaq fell 0.51%. ServiceNow remains down about a third this year despite strong Q1 subscription revenue and raised guidance.
Go toTop